FDA Recalls About

FDA Recalls

Food recalls
Drug recalls
Device recalls

Browse

All recalls

About

About us
Guides
Data sources
Privacy policy

Data

OpenFDA API

© 2026Civic Data · Data sourced from OpenFDA, updated weekly · Not affiliated with the U.S. Food and Drug Administration · Always verify against official FDA sources before acting

FDA Recalls
›Drug Recalls

FDA Drug Recalls

Recalls of prescription drugs, over-the-counter medications, and compounded pharmaceuticals.

Classification

All Class I Class II Class III

Status

All Ongoing Completed Terminated

Date

All time Past 30 days Past 12 months

Showing 241–260 of 436 recalls

Class IICompleted

Ranitidine Tablets, USP 150 mg, a.) 65 count bottles (NDC 49035-404-61) b.) 130 count bottles (NDC 49035-404-13) c.) 220 count bottles (NDC 49035-404-65) (Walmart) OTC

Dr. Reddy's Laboratories, Inc.

CGMP Deviations: Presence of NDMA impurity detected in product.

October 1, 2019 · DrugView details →

Class IICompleted

Ranitidine Tablets 75 mg, a.) 30 count bottles (NDC 63868-482-30), 60 count bottles (NDC 63868-482-60) (CDMA) OTC

Dr. Reddy's Laboratories, Inc.

CGMP Deviations: Presence of NDMA impurity detected in product.

October 1, 2019 · DrugView details →

Class IICompleted

Ranitidine Tablets, USP 150 mg, 40 count bottles, NDC 11673-849-40 (Target) OTC.

Dr. Reddy's Laboratories, Inc.

CGMP Deviations: Presence of NDMA impurity detected in product.

October 1, 2019 · DrugView details →

Class IICompleted

Ranitidine Tablets, USP 75 mg 30 count bottles (NDC 30142-131-30) (Kroger)

Dr. Reddy's Laboratories, Inc.

CGMP Deviations: Presence of NDMA impurity detected in product.

October 1, 2019 · DrugView details →

Class IICompleted

Ranitidine Tablets, USP 75 mg, NDC 57896-715 (GeriCare) OTC.

Dr. Reddy's Laboratories, Inc.

CGMP Deviations: Presence of NDMA impurity detected in product.

October 1, 2019 · DrugView details →

Class IICompleted

Ranitidine Tablets, USP 150 mg, a.) 24 count bottles (NDC 63868-480-24), b.) 50-count bottles (NDC 63868-480-50) (CDMA) OTC

Dr. Reddy's Laboratories, Inc.

CGMP Deviations: Presence of NDMA impurity detected in product.

October 1, 2019 · DrugView details →

Class IICompleted

Ranitidine Tablets, USP 75 mg, a.) 30- count bottles (NDC 0363-0131-30), b.) 80-count bottles (NDC 0363-0131-80) (Walgreens) OTC

Dr. Reddy's Laboratories, Inc.

CGMP Deviations: Presence of NDMA impurity detected in product.

October 1, 2019 · DrugView details →

Class IICompleted

Ranitidine Tablets, USP 150 mg, NDC 57896-717 (GeriCare) OTC

Dr. Reddy's Laboratories, Inc.

CGMP Deviations: Presence of NDMA impurity detected in product.

October 1, 2019 · DrugView details →

Class IICompleted

Ranitidine Tablets, USP 150 mg, a.) 24 count bottles (NDC 30142-505-34), b.) 50 count bottles (NDC 30142-505-50) (Kroger) OTC

Dr. Reddy's Laboratories, Inc.

CGMP Deviations: Presence of NDMA impurity detected in product.

October 1, 2019 · DrugView details →

Class IICompleted

Ranitidine Tablets, USP 150 mg, 190 count bottles (2x95) Tray (Sam's Club) OTC, NDC 150062076 UPC Code 078742089720

Dr. Reddy's Laboratories, Inc.

CGMP Deviations: Presence of NDMA impurity detected in product.

October 1, 2019 · DrugView details →

Class IICompleted

Ranitidine Tablets, USP 150 mg, a.) 95 count bottles (NDC 43598-808-62), b.) 220 count bottles (NDC 43598-808-65) (HCA) OTC.

Dr. Reddy's Laboratories, Inc.

CGMP Deviations: Presence of NDMA impurity detected in product.

October 1, 2019 · DrugView details →

Class IICompleted

Dr. Reddy's: Ranitidine Capsules 150 mg, Rx a.) 60 count bottles (NDC 55111-129-60) b.) 500 count bottles (NDC 55111-129-05)

Dr. Reddy's Laboratories, Inc.

CGMP Deviations: Presence of NDMA impurity detected in product.

October 1, 2019 · DrugView details →

Class IICompleted

Dr. Reddy's Ranitidine Tablets, USP 150 mg, 24 count bottles, NDC 55111-404-34 (OTC)

Dr. Reddy's Laboratories, Inc.

CGMP Deviations: Presence of NDMA impurity detected in product.

October 1, 2019 · DrugView details →

Class IICompleted

Dr. Reddy's Ranitidine Tablets, USP 75 mg, 60 count bottles, NDC 55111-131-60, (OTC)

Dr. Reddy's Laboratories, Inc.

CGMP Deviations: Presence of NDMA impurity detected in product.

October 1, 2019 · DrugView details →

Class IICompleted

Ranitidine Tablets, USP 150 mg, a.) 24 count bottles (NDC 0363-0010-34), b.) 65 count bottles (NDC 0363-0010-61) , c.) 95 count bottles (NDC 0363-0010-62), d.) 200 count bottles (NDC 0363-0010-01) (Walgreens) OTC

Dr. Reddy's Laboratories, Inc.

CGMP Deviations: Presence of NDMA impurity detected in product.

October 1, 2019 · DrugView details →

Class IICompleted

Dr. Reddy's Ranitidine Capsules, USP 300 mg, a.) 30 count bottles (NDC 55111-130-30) b.) 100 count bottles (NDC 55111-130-01)

Dr. Reddy's Laboratories, Inc.

CGMP Deviations: Presence of NDMA impurity detected in product.

October 1, 2019 · DrugView details →

Class IICompleted

Ranitidine Tablets, USP 150 mg, a.) 24 count bottles (NDC 71713-203-02), b.)95 count bottles (NDC 71713-203-05) (Thirty Madison) OTC.

Dr. Reddy's Laboratories, Inc.

CGMP Deviations: Presence of NDMA impurity detected in product.

October 1, 2019 · DrugView details →

Class IICompleted

Ranitidine Tablets, USP 75 mg, a.) 30 count bottles (NDC 69842-871-30) b.) 80 count bottles (NDC 69842-871-80) c.)160 count bottles (NDC 69842-871-37) (CVS) OTC

Dr. Reddy's Laboratories, Inc.

CGMP Deviations: Presence of NDMA impurity detected in product.

October 1, 2019 · DrugView details →

Class IICompleted

Equate Maximum Strength Ranitidine Tablets, USP 150 mg Acid Reducer 130 Tablets Distributed by Wal-Mart Stores, Inc. Bentonville, AR 72716 a) Twin Pack NDC: 49035-100-07; b) Single Pack NDC: 49035-100-00

Apotex Inc.

GGMP Deviations: Possible contamination with impurity N-nitrosodimethylamine (NDMA).

September 24, 2019 · DrugView details →

Class IICompleted

Equate Maximum Strength Ranitidine Tablets, USP 150 mg Acid Reducer Cool Mint Tablets Sugar Free 65 Tablets NDC: 49035-117-06 Distributed By: Wal-Mart Stores, Inc. Bentonville, AR 72716

Apotex Inc.

GGMP Deviations: Possible contamination with impurity N-nitrosodimethylamine (NDMA).

September 24, 2019 · DrugView details →

← PreviousPage 13 of 22Next →